Safety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant Melanoma

Clinical trial NCT00356460 · COMPLETED

Trial details

NCT number: NCT00356460
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Renal Cell Melanoma

Start date: 2006-09-01
Primary completion: 2009-05-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.